FilingSEC EDGAR8-K
Q32 Bio Appoints Chief Medical Officer and Chief Development Officer
· SEC accepted
StageExecutive Appointment
Filing content
Q32 Bio appointed José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer to support its transition into a late clinical-stage company.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…